Skip to main content
    I

    InfuSystems Holdings Inc (INFU)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $14.81
    +0.09 (+0.61%)

    Market Cap: $294.89M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InfuSystems Holdings Inc (INFU) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    InfuSystems Holdings reported revenue of $143.44M for the fiscal year ended Dec 31, 2025, up 6.4% from the year before. That year, net income was $6.63M with a net margin of 4.6%, operating cash flow was $24.41M and free cash flow was $23.85M. The quarter ended Sep 30, 2026 had revenue of $37.59M and net income of $3.16M.

    Revenue and Margins

    The operating margin was 8.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $70.50M, a compound annual rate of 8.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$143.44M+6.4%56.0%8.3%4.6%
    Dec 2024$134.86M+7.2%52.2%5.1%1.7%
    Dec 2023$125.78M+14.4%50.2%3.2%0.7%
    Dec 2022$109.91M+7.4%55.1%1.5%0.0%
    Dec 2021$102.38M+5.1%57.2%2.8%1.4%
    Dec 2020$97.39M+20.1%59.5%9.1%17.8%
    Dec 2019$81.11M+20.8%57.8%4.3%1.7%
    Dec 2018$67.14M-5.5%58.9%0.6%-1.6%
    Dec 2017$71.08M+0.8%61.0%-5.4%-29.1%
    Dec 2016$70.50MN/A55.5%1.4%-0.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 182.1% from the year before. In the quarter ended Sep 2026, net income rose 39.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$143.44M$134.86M$125.78M$109.91M$102.38M$97.39M$81.11M$67.14M$71.08M$70.50M
    Cost of revenue$63.14M$64.46M$62.68M$49.35M$43.85M$39.42M$34.23M$27.57M$27.72M$31.39M
    Gross profit$80.30M$70.40M$63.11M$60.56M$58.54M$57.97M$46.88M$39.57M$43.36M$39.11M
    Operating income$11.92M$6.89M$4.09M$1.65M$2.82M$8.83M$3.52M$415.00K-$3.81M$974.00K
    Net income$6.63M$2.35M$872.00K$18.00K$1.42M$17.33M$1.36M-$1.09M-$20.71M-$222.00K
    EBITDA$25.30M$19.41M$16.65M$14.96M$17.41M$22.84M$15.81M$11.72M$8.63M$11.76M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$37.59M$36.93M$33.68M$36.23M$36.49M$36.00M$34.72M$33.85M$35.32M$33.70M$32.00M$31.77M
    Gross profit$21.73M$21.41M$19.68M$20.43M$20.82M$19.87M$19.17M$18.22M$19.05M$16.67M$16.47M$16.71M
    Operating income$4.75M$4.15M$1.59M$3.71M$3.81M$3.78M$618.00K$2.62M$3.27M$1.85M-$845.00K$1.25M
    Net income$3.16M$3.23M$1.02M$2.04M$2.26M$2.60M-$267.00K$933.00K$1.81M$717.00K-$1.11M$72.00K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, long-term debt of $19.63M exceeded cash and equivalents by $16.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$100.56M$103.61M$102.92M$99.39M$97.59M$96.99M$79.22M$64.07M$68.88M$96.34M
    Current assets$36.34M$32.16M$30.62M$24.78M$22.07M$29.77M$19.30M$17.54M$17.67M$20.77M
    Cash and equivalents$3.19M$527.00K$231.00K$165.00K$186.00K$9.65M$2.65M$4.32M$3.47M$3.40M
    Total liabilities$43.23M$46.09M$50.61M$51.38M$49.31M$56.24M$56.89M$43.63M$37.93M$45.66M
    Short-term debtN/AN/A$1.47M$931.00K$349.00K$9.42M$8.08M$4.90M$3.54M$8.25M
    Long-term debt$19.63M$23.86M$29.10M$33.16M$32.75M$29.38M$30.30M$28.84M$25.35M$26.58M
    Shareholder equity$57.33M$57.53M$52.30M$48.00M$48.27M$40.75M$22.33M$20.44M$30.95M$50.69M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$104.52M$97.70M$98.66M$100.56M$98.88M$100.85M$104.28M$103.61M$105.30M$108.53M$104.85M$102.92M
    Total liabilities$40.37M$38.55M$39.91M$43.23M$43.41M$46.31M$49.13M$46.09M$49.79M$55.04M$52.57M$50.61M
    Cash and equivalents$9.11M$964.00K$2.11M$3.19M$955.00K$720.00K$1.51M$527.00K$380.00K$146.00K$822.00K$231.00K
    Shareholder equity$64.15M$59.15M$58.75M$57.33M$55.47M$54.53M$55.15M$57.53M$55.51M$53.49M$52.28M$52.30M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 97.7% of operating cash flow. Share repurchases came to 41.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$24.41M$20.46M$11.22M$17.52M$18.32M$20.28M$13.88M$11.39M$7.72M$7.91M
    Capital expenditures$560.00K$1.09M$1.02M$982.00K$980.00K$1.09M$2.93M$281.00K$2.76M$5.27M
    Free cash flow$23.85M$19.37M$10.20M$16.54M$17.34M$19.19M$10.95M$11.11M$4.96M$2.64M
    Dividends paidN/AN/A$4.27M$1.35M$1.12M$190.00K$252.00KN/A$0$0
    Share repurchases$9.87M$1.18M$153.00K$5.46M$560.00K$0$0$10.39M$0N/A
    Investing cash flow-$6.79M-$13.24M-$6.73M-$11.48M-$21.32M-$12.16M-$19.64M-$4.98M$918.00K-$5.34M
    Financing cash flow-$14.96M-$6.92M-$4.42M-$6.06M-$6.46M-$1.12M$4.10M-$5.56M-$8.56M$15.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$10.34M$6.78M$970.00K$7.13M$8.49M$7.01M$1.78M$7.93M$9.84M$2.31M$377.00K$4.66M
    Capital expenditures$73.00K$91.00K$157.00K$133.00K$79.00K$217.00K$131.00K$530.00K$43.00K$337.00K$182.00K$408.00K
    Free cash flow$10.27M$6.69M$813.00K$6.99M$8.41M$6.79M$1.65M$7.40M$9.80M$1.97M$195.00K$4.25M
    Last 12 quarters

    Frequently Asked Questions About INFU

    What is InfuSystems Holdings' annual revenue?

    InfuSystems Holdings reported revenue of $143.44M for the fiscal year ended Dec 31, 2025.

    How fast is InfuSystems Holdings' revenue growing?

    Revenue was up 6.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.3%.

    Is InfuSystems Holdings profitable?

    Yes. InfuSystems Holdings reported net income of $6.63M for the fiscal year ended Dec 31, 2025, with a net margin of 4.6%.

    How much free cash flow does INFU generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $24.41M minus capital expenditures of $560.00K produced free cash flow of $23.85M.

    How much debt does InfuSystems Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $19.63M and cash and equivalents of $3.19M.